KRAS in the clinic and conference

Bookmark and Share
Published: 9 Oct 2016
Views: 1445
Rating:
Save
Dr Ana Vivancos - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Dr Vivancos meets with ecancertv at ESMO 2016 to discuss how her lab is targeting KRAS mutations, with liquid biopsies guiding research.

She discusses clinical practice, working with lung adenocarcinomas, metastatic colorectal cancer and pancreatic cancer, and the opportunities of collaboration and professional development through the conference.

Considering the news from ESMO so far, Dr Vivancos anticipates novel biomarkers and immunotherapy having a significant influence over future standards of care.